Schellenberg R R, Foster A
Prostaglandins. 1984 Mar;27(3):475-82. doi: 10.1016/0090-6980(84)90205-3.
Responses to leukotrienes B4, C4, D4 and E4 were examined in human pulmonary artery and pulmonary vein preparations from surgical specimens. Leukotrienes C4 (LTC) and D4 (LTD) were potent contractants of pulmonary vein over the dose range of 10(-10) M to 10(-6) M, whereas they produced minimal contractions of human pulmonary artery only at concentrations of 10(-8) M or greater. Leukotriene E4 was less potent than LTC or LTD, and leukotriene B4 (LTB) at concentrations up to 10(-6) M had no effect upon either pulmonary veins or pulmonary arteries. Contractions of pulmonary vein by LTD were inhibited in a competitive manner by FPL 55712. Dose response characteristics of LTD and inhibition by FPL 55712 were similar for pulmonary venous and bronchial smooth muscle. We conclude that pulmonary vein smooth muscle has leukotriene receptors comparable to those of bronchial smooth muscle whereas pulmonary artery does not.
在取自手术标本的人肺动脉和肺静脉制剂中检测了对白三烯B4、C4、D4和E4的反应。在10(-10)M至10(-6)M的剂量范围内,白三烯C4(LTC)和D4(LTD)是肺静脉的强效收缩剂,而它们仅在浓度为10(-8)M或更高时才引起人肺动脉的最小收缩。白三烯E4的效力低于LTC或LTD,并且浓度高达10(-6)M的白三烯B4(LTB)对肺静脉或肺动脉均无影响。FPL 55712以竞争性方式抑制LTD对肺静脉的收缩作用。LTD的剂量反应特征以及FPL 55712的抑制作用在肺静脉和支气管平滑肌中相似。我们得出结论,肺静脉平滑肌具有与支气管平滑肌相当的白三烯受体,而肺动脉则没有。